Table 2 Characteristics of countries included in the analysis and summary of responses
From: Implementing new health interventions in developing countries: why do we lose a decade or more?
| Â | Included in sample | High- income | Upper- middle- income | Lower- middle- income | Low- income | No income category | Intervention implemented (%) | Not implemented | Did not respond |
|---|---|---|---|---|---|---|---|---|---|
Hepatitis B vaccine | 193 | 50 | 46 | 54 | 40 | 3 | 180 (93%) | 13 | 0 |
Haemophilus influenzae type B vaccine | 193 | 50 | 46 | 54 | 40 | 3 | 163 (84%) | 30 | 0 |
Rotavirus vaccine | 193 | 50 | 46 | 54 | 40 | 3 | 30 (16%) | 163 | 0 |
Pneumococcal vaccine | 193 | 50 | 46 | 54 | 40 | 3 | 61 (32%) | 132 | 0 |
Insecticide-treated mosquito net | 104 | 4 | 21 | 39 | 40 | 0 | 89 (86%) | 0 | 15 |
Rapid diagnostic test | 104 | 4 | 21 | 39 | 40 | 0 | 40 (38%) | 6 | 58 |
Artemisinin-based combination therapy | 104 | 4 | 21 | 39 | 40 | 0 | 63 (61%) | 12 | 29 |